NOVEL RECOMBINANT PLASMID HAVING SPECIFIC SEQUENCE

    公开(公告)号:JPS62115287A

    公开(公告)日:1987-05-26

    申请号:JP25566085

    申请日:1985-11-14

    Abstract: PURPOSE:A recombinant plasmid containing a gene to code 1st-29th peptide fragments among bovine growth hormone release factor peptide having secretion adjusting activity of growth hormone. CONSTITUTION:Novel recombinant plasmid pGRF29-28 consisting of 5406 pairs of bases having DNA sequence partially shown by formula II, a recombinant plasmid which can provide a host with ampicillin resistance, codes a peptide wherein a peptide sequence consisting of 6 amino acids of methionine-isoleucine- isoleucine-glutamic acid-glycine-alginine is fused to an amino end side of 1st-29th peptide fragment among bovine growth hormone release factor peptide by cleavage with restriction enzyme BclI and can free a DNA sequence consisting of 107 pairs of bases shown by formula I.

    SPECIFIC DNA SEQUENCE CONTAINING MODIFIED DIHYDROFOLIC ACID REDUCTASE GENE

    公开(公告)号:JPS61271990A

    公开(公告)日:1986-12-02

    申请号:JP11369285

    申请日:1985-05-27

    Abstract: PURPOSE:A DNA sequence, consisting of a specific base sequence and containing a gene of an enzyme capable of catalyzing a reaction for reducing dihydrofolic acid and producing tetrahydrofolic acid. CONSTITUTION:A DNA sequence expressed by the formula. The DNA sequence consists of a part coding dihydrofolic acid reductase protein of E. coli (sequence A at the 1- - 477-position), part on the upstream side thereof (sequence B at the -56- - -1-position) and part on the downstream side thereof (sequence C consisting of TAA at the 478- - 480-translation stopping number). The sequences (A) and (C) are the same as the sequence derived from a chromosome DNA of E. coli, and the sequence (B) is derived from a chemically synthesized DNA. The sequence (B) consists of a cleavage site of a restriction enzyme, a site of translation stopping group corresponding to the reading frame of three gene translations and ribosome linking sites for E. coli (DNA sequence of AGGA) and for B. subtilis (DNA sequence of AAAGGAGG).

    DEPROTECTION OF CYCLIC SILICON PROTECTING GROUP

    公开(公告)号:JPH01230594A

    公开(公告)日:1989-09-14

    申请号:JP5717288

    申请日:1988-03-10

    Abstract: PURPOSE:To eliminate protecting groups completely under mild conditions in a shortened time, being very beneficial in nucleic acid synthesis, by allowing a trialkylammonium fluoride to act on specific cyclic silicon-protecting derivatives. CONSTITUTION:(A) Trialkylammonium fluoride is allowed to act on (B) cyclic silicon-protecting groups of formula I (R, R' are alkyl, cycloalkyl, aryl, aralkyl, alkaryl; R'' is H, hydroxyl, protected hydroxyl; B is monovalent residue of nucleic acid base or its derivative to effect hydrolysis whereby the compound of formula II is obtained.

    PRODUCTION OF NUCLEOSIDE SILICON DERIVATIVE

    公开(公告)号:JPS63215693A

    公开(公告)日:1988-09-08

    申请号:JP4964587

    申请日:1987-03-04

    Abstract: PURPOSE:To obtain the titled compound useful as an intermediate in chemical synthesis of nucleic acids in one process, by reacting a nucleoside with a specific silicon halide in the presence of a silver salt of an acid and subsequently hydrolyzing the resultant reaction product. CONSTITUTION:A nucleoside expressed by formula I [B is (protected) nucleic acid base] is reacted with a silicon halide expressed by the formula R2SiX2 or XSiR'2OSiR'X (X is halogen; R and R' are tert-butyl or isopropyl) (preferably di-tert-butyldichlorosilane or tetraisopropyldichlorosilane) in the presence of a silver salt of an inorganic or organic acid (preferably silver nitrate or silver trifluorosulfonate) and the resultant reaction product is subsequently hydrolyzed to afford the aimed compound formula II or III.

    NOVEL RECOMBINANT PLASMID CONTAINING LEUCINE ENKEPHALIN GENE

    公开(公告)号:JPS61260885A

    公开(公告)日:1986-11-19

    申请号:JP10087885

    申请日:1985-05-13

    Abstract: PURPOSE:To construct a specific recombinant plasmid having a specific DNA sequence, by making it possible to cut out a DNA sequence coding leucine enkephalin consisting of 28 base pairs by cleavage with a restriction enzyme EcoRI. CONSTITUTION:A novel recombinant plasmid pLEG1 obtained by carrying out sorting out of a plasmid vector and chemical synthesis of a DNA coding leucine enkephalin, and passing the synthesized DNA through processes of integration into a plasmid vector, introduction of the resultant recombinant plasmid into Escherichia coli K12C600 strain, separation of microbial cells having the recombinant plasmid and separation of the plasmid. DNAs expressed by formulas I and II synthesized by the phosphoramidite solid phase synthesis method may be used as the DNA coding the leucine enkephalin.

Patent Agency Ranking